Peto T - Search Results

1

Prevalence and phenotype associations of complement factor I mutations in geographic atrophy.

Khan AH, Sutton J, Cree AJ, Khandhadia S, De Salvo G, Tobin J, Prakash P, Arora R, Amoaku W, Charbel Issa P, MacLaren RE, Bishop PN, Peto T, Mohamed Q, Steel DH, Sivaprasad S, Bailey C, Menon G, Kavanagh D, Lotery AJ. Khan AH, et al. Among authors: peto t. Hum Mutat. 2021 Sep;42(9):1139-1152. doi: 10.1002/humu.24242. Epub 2021 Jun 29. Hum Mutat. 2021. PMID: 34153144 Free PMC article.

2

Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study.

Tufail A, Patel PJ, Egan C, Hykin P, da Cruz L, Gregor Z, Dowler J, Majid MA, Bailey C, Mohamed Q, Johnston R, Bunce C, Xing W; ABC Trial Investigators. Tufail A, et al. BMJ. 2010 Jun 9;340:c2459. doi: 10.1136/bmj.c2459. BMJ. 2010. PMID: 20538634 Free article. Clinical Trial.

3

Age-related macular degeneration: the importance of family history as a risk factor.

Shahid H, Khan JC, Cipriani V, Sepp T, Matharu BK, Bunce C, Harding SP, Clayton DG, Moore AT, Yates JR; Genetic Factors in AMD Study Group. Shahid H, et al. Br J Ophthalmol. 2012 Mar;96(3):427-31. doi: 10.1136/bjophthalmol-2011-300193. Epub 2011 Aug 23. Br J Ophthalmol. 2012. PMID: 21865200

4

Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype.

Sofat R, Casas JP, Webster AR, Bird AC, Mann SS, Yates JR, Moore AT, Sepp T, Cipriani V, Bunce C, Khan JC, Shahid H, Swaroop A, Abecasis G, Branham KE, Zareparsi S, Bergen AA, Klaver CC, Baas DC, Zhang K, Chen Y, Gibbs D, Weber BH, Keilhauer CN, Fritsche LG, Lotery A, Cree AJ, Griffiths HL, Bhattacharya SS, Chen LL, Jenkins SA, Peto T, Lathrop M, Leveillard T, Gorin MB, Weeks DE, Ortube MC, Ferrell RE, Jakobsdottir J, Conley YP, Rahu M, Seland JH, Soubrane G, Topouzis F, Vioque J, Tomazzoli L, Young I, Whittaker J, Chakravarthy U, de Jong PT, Smeeth L, Fletcher A, Hingorani AD. Sofat R, et al. Among authors: peto t. Int J Epidemiol. 2012 Feb;41(1):250-62. doi: 10.1093/ije/dyr204. Epub 2012 Jan 13. Int J Epidemiol. 2012. PMID: 22253316 Free PMC article.

5

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.

IVAN Study Investigators; Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Wordsworth S, Reeves BC. IVAN Study Investigators, et al. Ophthalmology. 2012 Jul;119(7):1399-411. doi: 10.1016/j.ophtha.2012.04.015. Epub 2012 May 11. Ophthalmology. 2012. PMID: 22578446 Clinical Trial.

6

Diabetic retinopathy: pathogenesis, clinical grading, management and future developments.

Heng LZ, Comyn O, Peto T, Tadros C, Ng E, Sivaprasad S, Hykin PG. Heng LZ, et al. Among authors: peto t. Diabet Med. 2013 Jun;30(6):640-50. doi: 10.1111/dme.12089. Diabet Med. 2013. PMID: 23205608 Review.

7

Injection frequency and response to bevacizumab monotherapy for diabetic macular oedema (BOLT Report 5).

Sivaprasad S, Crosby-Nwaobi R, Heng LZ, Peto T, Michaelides M, Hykin P. Sivaprasad S, et al. Among authors: peto t. Br J Ophthalmol. 2013 Sep;97(9):1177-80. doi: 10.1136/bjophthalmol-2013-303168. Epub 2013 Jul 3. Br J Ophthalmol. 2013. PMID: 23823078 Clinical Trial.

8

Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial.

Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Culliford LA, Reeves BC; IVAN study investigators. Chakravarthy U, et al. Lancet. 2013 Oct 12;382(9900):1258-67. doi: 10.1016/S0140-6736(13)61501-9. Epub 2013 Jul 19. Lancet. 2013. PMID: 23870813 Free article. Clinical Trial.

9

Agreement between time-domain and spectral-domain optical coherence tomography in the assessment of macular thickness in patients with idiopathic macular telangiectasia type 2.

Mathew R, Sivaprasad S, Florea D, Leung I, Sallo F, Clemons T, Bird AC, Peto T. Mathew R, et al. Among authors: peto t. Ophthalmologica. 2013;230(3):144-50. doi: 10.1159/000353455. Epub 2013 Aug 24. Ophthalmologica. 2013. PMID: 23989133

10

Structural and functional measures of efficacy in response to bevacizumab monotherapy in diabetic macular oedema: exploratory analyses of the BOLT study (report 4).

Sivaprasad S, Crosby-Nwaobi R, Esposti SD, Peto T, Rajendram R, Michaelides M, Hykin P. Sivaprasad S, et al. Among authors: peto t. PLoS One. 2013 Aug 27;8(8):e72755. doi: 10.1371/journal.pone.0072755. eCollection 2013. PLoS One. 2013. PMID: 24013651 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,022 results

Search Page

Filters